In patients taking both -blockers and sulfonylureas, the risk of hypoglycemia increases primarily due to which pharmacodynamic interaction? 47 a.Increased peripheral insulin resistanceb.Inhibited hepatic glucose output and suppressed adrenergic symptomsc.Enhanced insulin release due to -blockaded.Reduced renal clearance of sulfonylureas
[Solved]: In patients taking both -blockers and…
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.
